Results 101 to 110 of about 41,400 (225)

Albumin-heparin microspheres as carriers for cytostatic agents [PDF]

open access: yes, 1990
Much work has been done on adriamycin-loaded albumin microspheres (Alb-MS) for chemoembolization [1–4], the rationale being that site-specific drug delivery may increase the therapeutic efficacy of the drug. Alb-Ms are being investigated because of their
Bae, Y.H.   +6 more
core   +2 more sources

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study

open access: yesLiver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background A significant proportion of patients presenting a primary sclerosing cholangitis (PSC) will require liver transplantation (LT). The present study aimed to investigate graft loss and patient death in a large cohort of patients. Methods We conducted a nationwide multicenter retrospective study including all adult patients transplanted
Florian Veyre   +35 more
wiley   +1 more source

Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results

open access: yesRadiology and Oncology, 2017
The aim of the study was to retrospectively evaluate the symptom control, tumour response, and complication rate in patients with liver-predominant metastatic neuroendocrine tumours treated with transarterial chemoembolization using doxorubicin-eluting ...
Bonne Lawrence   +8 more
doaj   +1 more source

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation

open access: yes, 2014
Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare.
Breen, David J.   +12 more
core   +2 more sources

Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial

open access: yesJournal of Hepatocellular Carcinoma, 2021
Li-Zhou Wang,1,* Xiao-Xia Hu,2,* Xiang-Chun Shen,2,3 Tian-Cheng Wang,4 Shi Zhou1 1Department of Interventional Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, People’s Republic of China; 2The State Laboratory ...
Wang LZ, Hu XX, Shen XC, Wang TC, Zhou S
doaj  

Arterial chemoembolization for hepatocellular carcinoma

open access: yesWorld Journal of Gastroenterology, 1998
AIM:To study the therapeutic effects of transcatheter arterial three-segment chemoembolization for hepatocellular carcinoma (HCC).METHODS: According to the anatomy of vessels, the tumor capillary networks, muscular arterioles and feeding arteries were successively occluded using lipiodol ultra-fluid (LUF), sinobufagin microsphere (SBMs) and particles ...
Jian, Fan   +5 more
openaire   +2 more sources

Engineered Optical Fibers for Deep‐Tissue Applications

open access: yesAdvanced Optical Materials, Volume 14, Issue 10, 13 March 2026.
This review establishes a foundational framework for designing optical fibers for deep‐tissue medicine. It systematically links material innovations like polymers and hydrogels with structural paradigms to enable state‐of‐the‐art diagnostics, including endoscopy and biosensing, and targeted therapeutics, guiding future clinical translation.
Yuzhen Li   +16 more
wiley   +1 more source

Chemoembolization agents for cancer treatment

open access: yesEuropean Journal of Pharmaceutical Sciences, 2011
Chemoembolization has been used in the field of interventional oncology. Although practiced widely, it has only recently been demonstrated that the use of transarterial chemoembolization (TACE) provides a survival benefit based on randomized controlled trials.
Kin Y, Tam   +2 more
openaire   +2 more sources

Current Status of Multidisciplinary Treatment Strategies for Hepatocellular Carcinoma in the Era of Advanced Systemic Therapies

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 2, Page 325-335, March 2026.
ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi   +4 more
wiley   +1 more source

Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives [PDF]

open access: yes, 2015
In the last decade trans-arterial radioembolization has given promising results in the treatment of patients with intermediate or advanced stage hepatocellular carcinoma (HCC), both in terms of disease control and tolerability profile.
Bargellini, Irene   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy